Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swedish (OMX) Clinical Research and Equipment Industry Analysis

UpdatedJun 25, 2026
DataAggregated Company Financials
Companies9
  • 7D5.4%
  • 3M15.1%
  • 1Y-10.1%
  • YTDn/a

In the last week, the Clinical Research and Equipment industry is up 5.4%, with AddLife up 6.2%. In contrast, the industry has lost 10% in the last 12 months. As for the next few years, earnings are expected to grow by 19% per annum.

Industry Valuation and Performance

Has the Swedish Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 25 Jun 2026SEK 30.6bSEK 14.6b-SEK 871,304,353.0035.8x-35.2x2.1x
Sat, 23 May 2026SEK 30.0bSEK 14.6b-SEK 850,163,077.0037.7x-35.3x2.1x
Mon, 20 Apr 2026SEK 31.3bSEK 14.6b-SEK 971,664,077.0036.3x-32.2x2.1x
Wed, 18 Mar 2026SEK 27.1bSEK 14.6b-SEK 838,374,077.0032.7x-32.3x1.9x
Fri, 13 Feb 2026SEK 26.7bSEK 14.9b-SEK 555,615,427.0032.1x-48.1x1.8x
Sun, 11 Jan 2026SEK 30.7bSEK 14.9b-SEK 744,515,427.0048x-41.3x2.1x
Tue, 09 Dec 2025SEK 33.0bSEK 14.9b-SEK 744,515,427.0055.3x-44.3x2.2x
Thu, 06 Nov 2025SEK 35.8bSEK 14.7b-SEK 742,825,012.0052x-48.3x2.4x
Sat, 04 Oct 2025SEK 34.5bSEK 14.7bSEK 61.3m58.7x562.8x2.4x
Mon, 01 Sep 2025SEK 34.9bSEK 14.7bSEK 60.9m58.4x573.9x2.4x
Wed, 30 Jul 2025SEK 36.6bSEK 14.8bSEK 186.0m61.8x196.6x2.5x
Fri, 27 Jun 2025SEK 45.9bSEK 16.6bSEK 405.8m70.1x113x2.8x
Sun, 25 May 2025SEK 45.0bSEK 16.6bSEK 401.6m68.5x112.1x2.7x
Tue, 22 Apr 2025SEK 36.9bSEK 16.6bSEK 609.4m39.6x60.5x2.2x
Thu, 20 Mar 2025SEK 37.6bSEK 16.6bSEK 614.9m38x61.1x2.3x
Sat, 15 Feb 2025SEK 43.7bSEK 17.0b-SEK 1,038,511,426.0042.5x-42.1x2.6x
Mon, 13 Jan 2025SEK 43.7bSEK 16.7b-SEK 1,152,911,426.0049.5x-37.9x2.6x
Wed, 11 Dec 2024SEK 44.2bSEK 16.7b-SEK 1,152,911,426.0051.5x-38.4x2.6x
Fri, 08 Nov 2024SEK 43.3bSEK 16.8b-SEK 958,019,827.0050.4x-45.2x2.6x
Sun, 06 Oct 2024SEK 47.2bSEK 16.7b-SEK 988,175,491.0058.9x-47.7x2.8x
Tue, 03 Sep 2024SEK 49.2bSEK 16.7b-SEK 987,374,492.0062.7x-49.8x2.9x
Thu, 01 Aug 2024SEK 50.4bSEK 16.7b-SEK 1,128,120,510.0064x-44.7x3x
Sat, 29 Jun 2024SEK 42.0bSEK 16.3b-SEK 1,188,686,510.0055.3x-35.3x2.6x
Mon, 27 May 2024SEK 42.2bSEK 16.3b-SEK 1,188,686,510.0060.1x-35.5x2.6x
Wed, 24 Apr 2024SEK 37.5bSEK 16.0b-SEK 1,122,732,213.0035.9x-33.4x2.3x
Fri, 22 Mar 2024SEK 39.4bSEK 16.0b-SEK 1,122,792,210.0036.3x-35.1x2.5x
Sun, 18 Feb 2024SEK 41.0bSEK 16.0b-SEK 1,409,735,350.0050.7x-29.1x2.6x
Tue, 16 Jan 2024SEK 37.0bSEK 15.5b-SEK 1,393,723,683.0044.9x-26.5x2.4x
Thu, 14 Dec 2023SEK 35.1bSEK 15.5b-SEK 1,393,723,683.0042.4x-25.2x2.3x
Sat, 11 Nov 2023SEK 31.2bSEK 15.4b-SEK 1,256,647,710.0034x-24.8x2x
Mon, 09 Oct 2023SEK 26.1bSEK 15.1b-SEK 1,134,516,711.0036.2x-23x1.7x
Wed, 06 Sep 2023SEK 30.0bSEK 15.1b-SEK 1,134,263,831.0041x-26.4x2x
Fri, 04 Aug 2023SEK 31.9bSEK 15.1b-SEK 213,871,038.0046.3x-149x2.1x
Sun, 02 Jul 2023SEK 36.5bSEK 14.6b-SEK 172,476,038.0036.1x-211.7x2.5x
Price to Earnings Ratio

-211.7x


Total Market Cap: SEK 36.5bTotal Earnings: -SEK 172,476,038.00Total Revenue: SEK 14.6bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Clinical Research and Equipment Industry Price to Earnings3Y Average 21.6x202420252026
Current Industry PE
  • Investors are pessimistic on the Swedish Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 2.4x is higher than the industry's current PS ratio of 2.1x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences Tools and Services industry have deteriorated over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Comparison

How does Swedish Clinical Research and Equipment compare with similar industries?

SE Market-0.80%
Healthcare2.52%
Life Sciences5.43%
Clinical Research and Equipment5.43%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ALIF B AddLifeSEK 166.806.2%
+SEK 1.2b		-7.5%PE35.8x
MCAP MedCapSEK 502.504.6%
+SEK 328.9m		13.6%PE33.5x
BICO BICO GroupSEK 16.624.0%
+SEK 45.2m		-51.6%PS0.8x
GENO Genovis AB (publ.)SEK 18.902.2%
+SEK 26.4m		-28.4%PE51.4x
ATANA AttanaSEK 0.00525.0%
+SEK 2.6m		-75.0%PS4.5x

Latest News

IDLDX
SEK 0.43
IDL Diagnostics
7D
1.9%
1Y
-15.8%
ALIF B
SEK 166.80
AddLife
7D
6.2%
1Y
-7.5%
ATANA
SEK 0.004
Attana
7D
-20.0%
1Y
-80.0%
MCAP
SEK 502.50
MedCap
7D
4.6%
1Y
13.6%
MAGLE
SEK 1.06
Magle Chemoswed Holding
7D
2.9%
1Y
-96.1%
PRO
SEK 10.30
Promimic
7D
-1.0%
1Y
-42.8%
LEVBIO
SEK 0.26
Level Bio
7D
-11.5%
1Y
-11.5%
BICO
SEK 16.62
BICO Group
7D
4.0%
1Y
-51.6%
GENO
SEK 18.90
Genovis AB (publ.)
7D
2.2%
1Y
-28.4%
Analysis Article • May 01

Genovis AB (publ.) Just Missed Earnings - But Analysts Have Updated Their Models

Genovis AB (publ.) ( STO:GENO ) shareholders are probably feeling a little disappointed, since its shares fell 4.4% to...
PEXA B
SEK 0.23
PExA
7D
-1.7%
1Y
-40.4%